Monotherapy with GI262570, a non-thiazolidinedione PPARγ agonist, reduces triglyceride and increases HDL-C in patients with type 2 diabetes

被引：0
|
作者：
Fiedorek, FT
Wilson, GG
Abou-Donia, M
Frith, L
Patel, J
机构：
[1] Glaxo Wellcome Co, Res Triangle Pk, NC USA
[2] PPA2005 Study Grp, Greenford, Middx, England
来源：
DIABETOLOGIA | 2000年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
727
引用
收藏
页码：A189 / A189
页数：1
相关论文
共 50 条
  • [21] Triglyceride to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio, a Simple but Effective Indicator in Predicting Type 2 Diabetes Mellitus in Older Adults
    Liu, Hongzhou
    Liu, Jing
    Liu, Jixiang
    Xin, Shuanli
    Lyu, Zhaohui
    Fu, Xiaomin
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [22] A longitudinal study on the impact of the TyG Index and TG/HDL-C ratio on the risk of type 2 diabetes in Chinese patients with prediabetes
    Chen, Bo
    Zeng, Jingjing
    Fan, Menglin
    You, Qiqi
    Wang, Chenyue
    Wang, Ke
    Qin, Minghui
    Xu, Shaoyong
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [23] Effectiveness of the TG/HDL-C ratio to improve GLP-1 prescription in patients with type 2 diabetes in primary care
    Cuevas Fernandez, F. J.
    Garcia Marrero, M. R.
    Iglesias Giron, M. J.
    Perez de Armas, A. A.
    Cerdena Rodriguez, E.
    Cabrera Leon, A.
    Aguirre-Jaime, A.
    MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 (08): : 521 - 530
  • [24] ARE THERE ANY CORRELATIONS BETWEEN RATIO LDL-C/HDL-C AND LIPOPROTEIN(A) WITH INSULIN RESISTANCE IN TYPE 2 DIABETES PATIENTS WITH ABDOMINAL OBESITY?
    Novida, H.
    Murtiwi, S.
    Tjokroprawiro, A.
    Pranoto, A.
    Sutjahjo, A.
    Adi, S.
    Wibisono, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S208 - S209
  • [25] Total cost reduction in type 2 diabetes mellitus (T2DM) patients treated with pioglitazone (PIO) based therapies versus non-thiazolidinedione (non-TZD) based therapies
    Baran, R. W.
    Xu, Y.
    Vallarino, C.
    Pandya, B.
    VALUE IN HEALTH, 2007, 10 (06) : A263 - A263
  • [26] The correlation among the serum dipeptidyl peptidase IV activity the serum HDL-C and HbA1c levels in patients with type 2 diabetes
    Varga, T.
    Somogyi, A.
    Lengyel, G.
    Sarman, B.
    Tulassay, Z.
    Selmeci, L.
    Firneisz, G.
    DIABETOLOGIA, 2007, 50 : S364 - S364
  • [27] Marked HDL cholesterol benefit in patients with low HDL-C and type 2 diabetes or imparied glucose tolerance with combined treatment of pioglitazone and low dose nicotinic acid
    Tawakol, R
    King, AB
    DIABETES, 2004, 53 : A147 - A148
  • [28] Association of rs2000999 in the haptoglobin gene with total cholesterol, HDL-C, and LDL-C levels in Mexican type 2 diabetes patients
    Suarez-Sanchez, Fernando
    Vazquez-Moreno, Miguel
    Herrera-Lopez, Ema
    Gomez-Zamudio, Jaime H.
    Peralta-Romero, Jose J.
    Castelan-Martinez, Osvaldo D.
    Cruz, Miguel
    Parra, Esteban J.
    Valladares-Salgado, Adan
    MEDICINE, 2019, 98 (39)
  • [29] LDL-C/HDL-C ratio associated with carotid intima-media thickness and carotid plaques in male but not female patients with type 2 diabetes
    Du, Rong
    Li, Mingxia
    Wang, Xi
    Wang, Suyuan
    Li, Sheyu
    Tian, Haoming
    Wu, Yunhong
    Zhang, Chenghui
    CLINICA CHIMICA ACTA, 2020, 511 : 215 - 220
  • [30] Effects of rosuvastatin and atorvastatin on non-HDL-C in patients with type 2 diabetes: Results of the ANDROMEDA study
    Betteridge, DJ
    Gibson, M
    DIABETES, 2004, 53 : A227 - A227
12345